Speaker illustration

Doctor Veronica Angela Rial Baston

Golden Jubilee National Hospital, Glasgow (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology
Heart Failure Association

Risk of infective endocarditis after trans-catheter aortic valve replacement and surgery. Meta-analysis of 4 randomized studies and 3754 patients

Event: ESC Congress 2018

Topic: Aortic Valve Intervention

Session: Operative and minimal invasive options for treating heart diseases

Thumbnail

Facing malignant pericardial effusion. What to do first: pericardiocentesis or percutaneous balloon pericardiotomy?

Event: ESC Congress 2018

Topic: Intervention and Surgery

Session: Pericardial disease - Tumors of the heart

Thumbnail

Diabetes, deafness and hypertrophic cardiomyopathy: is it just a coincidence?

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Cardiomyopathy

Session: Clinical Case Corner 3 - Metabolic issues in heart failure: don't forget periphery!

Thumbnail

How do we get the patients to stop smoking in cardiac rehabilitation programs?

Event: EuroPrevent 2017

Topic: Smoking (Sports Cardiology)

Session: Risk factors: others_Part 3

Thumbnail

Do metabolically healthy obese develop coronary heart disease?

Event: EuroPrevent 2017

Topic: Obesity

Session: Diabetes/ Lipids/Obesity/Nutrition_Part 3

Thumbnail

Bispectral index: an early predictor of neurological outcomes in cardiac arrest survivors

Event: ESC Congress 2016

Topic: CPR (cardiopulmonary resuscitation)

Session: Cardiac arrest

Thumbnail

In patients with systolic dysfunction, what does being young imply?

Event: HEART FAILURE 2016

Topic: Disease management programmes

Session: Disease management programmes

Thumbnail

Diabetes in cardiac rehabilitation programs: how does it influence outcomes in patients with systolic dysfunction?

Event: HEART FAILURE 2016

Topic: Metabolism / Diabetes mellitus

Session: Metabolism / Diabetes mellitus / Obesity

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb